Skip to main content
Sphingosine-1-phosphate

Sphingosine-1-phosphate

Search complete. 5 mentions across 3 episodes found for "Sphingosine-1-phosphate".

Sep 15, 2026

Darshan ShahHOST
47:44
Yes.
Jeffrey WiegersGUEST
47:44
It's S1P for Mu cells.
Darshan ShahHOST
47:46
Mm-hmm.
Jeffrey WiegersGUEST
47:46
Sphingosine 1-phosphate.
ChapaHOST
17:30
OK, now there's some medications that once you stop them, they're so good at suppressing flares that once you stop it, it runs the risk of immediate relapse.
ChapaHOST
17:40
Those are like S1P modulators.
ChapaHOST
17:43
And for those, you should not abruptly discontinue that.
ChapaHOST
17:47
The thought is, hey, you can continue using this or bridge to something else, but keep using that medication, this S1P modulator regularly.
ChapaHOST
17:55
up until like 30 to 34 weeks, and then you can stop.
ChapaHOST
17:59
So it's not like everything has to be stopped straight off if you're considering pregnancy.
Lucy CoxHOST
9:05
Some medications must be avoided in pregnancy.
Lucy CoxHOST
9:08
For example, methotrexate, JAK inhibitors, and S1P modulators must be stopped three months before conception.
Lucy CoxHOST
9:17
In other situations, the gastroenterology team will weigh up the risk of harm from relapse against any potential harms from the medication and will often opt to continue.
Nick KendrewHOST
9:27
Preconception advice for men now, and there is little evidence about the effect of IBD on male fertility.

6 MINS LATER

Nick KendrewHOST
15:54
Active Crohn's disease and pelvic surgery may reduce fertility.
Lucy CoxHOST
15:59
All women taking medication or with active disease should be referred to a specialist during pregnancy.
Lucy CoxHOST
16:05
JAK inhibitors, S1P inhibitors, and methotrexate should be stopped three months prior to conception, but many other drugs in IBD are low risk.
Lucy CoxHOST
16:15
Women using sulfasalazine or at risk of malabsorption need high-dose folic acid at a dose of five milligrams per day.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.